EQT Partners AB is a private equity and venture capital firm based in Stockholm, Sweden, with a global presence through additional offices in major cities across Europe, Asia, and North America. Founded in 1994, EQT specializes in a wide array of investment strategies, including expansion capital, buyouts, and growth equity, focusing on medium to large-sized companies with consistent cash flows or significant intrinsic value. The firm targets various sectors, such as healthcare, technology, energy, and infrastructure, and emphasizes investments in mid-market situations, over-leveraged companies, and distressed assets. EQT's investment approach is characterized by taking controlling or co-controlling equity stakes in its portfolio companies and actively participating in their management, often securing board seats. The firm typically holds investments for four to eight years, aiming to enhance growth and create long-term value for stakeholders.
Unit 1507-1508 CITIC Square 1168, Nanjing Road West, Shanghai 200041, China
Andreas Aschenbrenner
Partner
Fouad Azzam
General Partner
Peter Balslev
Managing Director
Gregory Bernstein
Associate
Lennart Blecher
Deputy Managing Partner
Clemens van Blitterswijk
Founder of LSP Health Economics Fund
Carolina Brochado
Partner
Brian Chang
Partner
Hans Clevers
Venture Partner
Rudy Dekeyser
Co-Founder Managing Director
Johan Dettel
Partner
Christina Drews
COO and Executive Committee
Victor Englesson
Partner
Stephen Escudier
Partner
Andreas Fischer
Partner
Fabian Grone
Partner, Head of Asia
Andreas Huber
Partner
Lars Jörnow
Partner
Kasper Grundtvig Knokgaard
Partner
John de Koning
General Partner
Kees Koolen
Partner
Ulrich Kollensperger
Partner
Nicholas Macksey
Partner
Robert Maclean
Partner
Martin Mix
Managing Director
Joep Muijrers
General Partner
Jörg Neermann
Partner
Suzana Peric
Director
Anne Portwich
Partner
Johannes Reichel
Partner
Carl Johan Renstrom
Partner
Niklas Ringby
Partner
Darlene Sammon
Partner
Carlos Santana
Partner
Christian Sinding
Managing Partner and CEO
Jan Stypulkowski
Managing Director
Jan Vesely
Partner
Fabian Wasmus
Partner
Mark Wegter
Managing Partner
Matthias Wittkowski
Partner
Fredrik Atting
Partner
535 past transactions
EAGLE RAILCAR SERVICES
Acquisition in 2025
EAGLE RAILCAR SERVICES is one of the nation's leading independent providers of railcar repair services.
ReliaQuest
Private Equity Round in 2025
ReliaQuest is a cybersecurity company founded in 2007 and headquartered in Tampa, Florida. It offers a cloud-native security platform called GreyMatter, which provides comprehensive visibility across Security Information and Event Management (SIEM), Endpoint Detection and Response (EDR), and multi-cloud environments. This platform is designed to automate and streamline the security lifecycle, enabling organizations to enhance their security posture while minimizing data loss and business disruptions. By facilitating real-time data analysis and contextual interpretation, ReliaQuest helps clients make informed security decisions and maintain compliance, ultimately fostering security confidence and resilience against potential breaches.
Scale Microgrid Solutions
Acquisition in 2025
Scale Microgrid Solutions designs, builds, operates, and finances on-site power systems for commercial and industrial facilities across North America. Founded in 2016 and based in Ridgewood, New Jersey, the company specializes in creating multi-resource clean energy microgrids that support renewable energy generation for daily operations and during power outages. Their offerings include the rapid response modular microgrid (R2M2), which optimizes solar power, battery storage, and dispatchable generation. By providing fully-financed microgrids and distributed energy services, Scale Microgrid Solutions aims to deliver sustainable and reliable power while alleviating the complexities traditionally associated with microgrid development. Their approach ensures clients benefit from innovative energy technologies, contributing to a cleaner and more resilient energy infrastructure.
ju:niz
Acquisition in 2024
JUNIZ focuses on sustainable real estate and renewable energy solutions, including large-scale energy storage systems.
ATB Therapeutics
Series A in 2024
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Vinted
Secondary Market in 2024
Vinted operates an online marketplace intended to make second-hand the first choice. Its platform offers a peer-to-peer marketplace for girls and women to buy, sell, and swap clothes with an online chatting feature, enabling users to shop with ease at low cost.
OX2
Acquisition in 2024
OX2 is a company focused on providing renewable energy solutions, including the development and sale of wind and solar farms. They operate in several countries across Europe, such as Sweden, Finland, Poland, France, Lithuania, Norway, Spain, Italy, Estonia, and Romania. In addition to their core activities in solar and onshore and offshore wind farms, OX2 is also involved in energy storage projects and the development of hydrogen solutions. The company emphasizes technical and business management solutions to support its various energy initiatives.
PanTera
Series A in 2024
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
Compass Education
Private Equity Round in 2024
Compass Education is a cloud-based school management platform designed to enhance parent engagement while reducing administrative burdens for educational institutions. Operating in regions including Victoria, New South Wales, Brisbane, and Dublin, the platform offers a versatile student information system that supports multiple languages and currencies. It features a wide array of modules, including attendance tracking, reporting, parent communication, student well-being, and learning management. Additionally, Compass Education facilitates staff development, online payments, event management, and data analytics, enabling schools to streamline their processes. By allowing administrators to efficiently manage school data and generate reports, the platform helps them focus on fostering strong connections within the school community.
PropertyGuru
Acquisition in 2024
PropertyGuru Limited is a property technology company that operates online property classifieds marketplaces across Singapore, Vietnam, Malaysia, Thailand, and Indonesia. Established in 2006 and headquartered in Singapore, the company connects property agents and developers with consumers seeking residential and commercial properties for sale or rent. Its flagship website, PropertyGuru.com.sg, serves as Singapore's leading property portal, attracting over 4.5 million users who access more than 50 million pages. PropertyGuru offers a range of services, including digital marketing for property agents, software solutions for sales process automation aimed at developers, and a digital mortgage marketplace. Additionally, the company provides consultancy services for banks, valuers, and property developers, further enhancing its role in the real estate ecosystem.
KJ Environment
Acquisition in 2024
KJ Environment is an environmental and energy infrastructure specialist is establishing a scaled and diverse end-to-end waste treatment platform focusing on plastic recycling and waste-to-electricity conversion.
Acronis
Acquisition in 2024
Acronis, Inc. specializes in data protection and cybersecurity solutions, offering a comprehensive range of services that include backup software, disaster recovery, and secure data access for consumers and businesses of all sizes. Founded in 2000 and headquartered in Woburn, Massachusetts, Acronis provides tools for physical, virtual, and cloud environments, ensuring the protection of data across various devices and operating systems. The company's offerings include the Acronis AnyData engine, which safeguards data across diverse storage locations, and Acronis Files Connect, facilitating file access for Mac users. Acronis also delivers integrated cyber protection through its innovative Cyber Protect solution, combining antivirus, backup, and endpoint protection management powered by artificial intelligence. With a global presence in over 150 countries and a customer base that includes service providers and sectors such as public, healthcare, and publishing, Acronis has established itself as a leader in the field, supporting over 750,000 businesses worldwide.
Asceneuron
Series C in 2024
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases. Tauopathies are currently untreatable neurodegenerative diseases that rapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
FlixBus
Private Equity Round in 2024
FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.
Peak3
Series A in 2024
Peak3 is a developer of insurtech software that delivers technical solutions and professional services to businesses. The company focuses on providing digital insurance options that are affordable and easily accessible, catering to the increasing demands of on-demand customers. By leveraging digital ecosystems, Peak3 enables users to redefine the insurance landscape and seamlessly integrate relevant protection into their customer journeys. Through its innovative platform, Peak3 aims to simplify the insurance process and enhance the overall experience for users.
Perficient
Acquisition in 2024
Perficient is an information technology consulting firm that specializes in software development and digital consultancy services. The company assists clients in leveraging Internet-based technologies to enhance productivity and competitiveness, while also strengthening relationships with customers, suppliers, and partners. Perficient offers a comprehensive range of services, including big data analytics, technology platform implementations, enterprise content management, portals and collaboration, management consulting, custom applications, business integration, business process management, and customer relationship management. It primarily serves clients in the healthcare, financial services, retail, and electronics industries, with most of its revenue generated in the United States.
WSO2
Acquisition in 2024
WSO2 Inc. specializes in open-source enterprise middleware solutions, catering to a diverse range of sectors, including healthcare, finance, and technology. Founded in 2005 and headquartered in Mountain View, California, WSO2 provides a comprehensive platform that allows enterprise architects to build, integrate, manage, secure, and analyze APIs, applications, and microservices across various environments, including on-premises and cloud. Its offerings include WSO2 Developer Studio for application development, WSO2 Private PaaS for hosting middleware products, and cloud solutions such as WSO2 App Cloud and WSO2 API Cloud, which facilitate application development and enable enterprises to share capabilities globally. WSO2 also addresses customer identity and access management needs through WSO2 Identity Cloud, incorporating user feedback to enhance its services. The company supports thousands of enterprises, executing over 60 trillion transactions and managing more than 1 billion identities annually, with a workforce of over 800 employees across multiple international locations.
Universidad Europea
Acquisition in 2024
Universidad Europea is an innovative institution geared towards adding value to society and contributing to its progress.
Binx
Series F in 2024
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.
Avetta
Acquisition in 2024
Avetta connects organizations with qualified suppliers, contractors, and vendors. As a renowned contractor prequalification company, PICS was created more than a decade ago with a focus on improving safety. In just a few years, PICS' world-class contractor prequalification service has become an industry leader. The company is a fast-growing contractor management company in the world. PICS ensures that your suppliers are prequalified to work in a safe and sustainable manner.
Onward
Post in 2024
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
Tubulis
Series B in 2024
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.
Phagenesis
Series D in 2024
Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
Believe
Post in 2024
Believe is a digital distributor focused on independent music, dedicated to supporting local artists and labels throughout their digital journeys. The company operates primarily through two segments: Premium Solutions and Automated Solutions. Premium Solutions involves the sale, promotion, and delivery of digital content for artists and labels, where Believe develops their catalogs across various digital platforms and social media, utilizing a revenue-sharing model. In contrast, Automated Solutions allows artists to distribute their audio content through the TuneCore platform, enabling a more streamlined and automated approach to reaching streaming services and social media. By prioritizing justice, expertise, respect, and transparency, Believe aims to empower independent musicians and enhance their visibility in the digital landscape.
Onera Health
Series C in 2024
Onera Health, Inc. specializes in providing innovative sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, Onera Health has developed advanced sleep diagnostic patch systems that collect and analyze sleep data. These systems not only enhance the diagnosis of sleep-related ailments but also have potential applications in monitoring various chronic health conditions. By delivering comprehensive sleep test data to healthcare providers, Onera Health aims to improve patient care and reduce healthcare costs, ultimately enhancing the health and quality of life for individuals globally.
InstaVolt
Private Equity Round in 2024
InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle. They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastest charging available. They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions. Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution. According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country. They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.
Indium Software
Acquisition in 2023
Indium Software is a rapidly expanding digital engineering services company that specializes in delivering innovative solutions in applications and data. The firm leverages advanced technologies, including Generative AI and data analytics, to offer a wide array of services such as Low-Code Development, Data Engineering, AI/ML, and Quality Engineering. Indium's expertise extends to various domains, including application engineering, cloud engineering, DevOps, digital assurance, and gaming. By focusing on these next-generation offerings, Indium aims to help clients effectively harness technology to achieve measurable business outcomes.
Next One Technology
Private Equity Round in 2023
Next One Technology operates within the cloud management and information technology sectors, focusing on the construction, contracting, and service industries. The company develops cloud-based systems, including Next Project and Next Field, which are designed to streamline project administration and enhance control over financial and payroll processes for businesses of all sizes. By providing user-friendly tools and environments, Next One Technology aims to improve efficiency, facilitate growth, and increase profitability for its clients. Additionally, the company is dedicated to making technology education accessible, offering resources that enable individuals to learn tech skills and upskill software teams, thus simplifying developer workflows.
HVD Group
Private Equity Round in 2023
HVD Group offers cloud-based end-to-end field service management and enterprise resource planning software with key functionalities such as order, project and asset management, scheduling, time reporting, procurement and documentation handling.
LUMA Vision
Series A in 2023
LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. By leveraging advanced four-dimensional imaging and artificial intelligence, LUMA Vision aims to transform electrophysiology and structural heart interventions. Their technology facilitates real-time tissue analysis, enabling healthcare professionals to perform cardiac procedures more effectively. This innovation is designed to improve patient outcomes, enhance procedural safety, and ultimately lower costs within the healthcare system.
Zeus Industrial Products
Acquisition in 2023
Zeus Industrial Products operates as a polymer extrusion manufacturer and material science innovator. Zeus Industrial Products offers fluoropolymers, custom extruded products, heavy construction products, heavy wall products, convoluted products, PTFE heat shrink products and FEP heat shrink products.
Shinobi Therapeutics
Series A in 2023
Shinobi Therapeutics specializes in the development of cell therapies that leverage hypoimmune CD8αβ iPS-T cells to interact with the immune system for the treatment of cancer and various genetic diseases. The company's innovative approach incorporates advanced immune evasion technology to enhance the effectiveness and accessibility of these therapies. By focusing on durable responses and the potential for redosing, Shinobi aims to reduce costs and improve patient outcomes in the healthcare sector.
Heritage Environmental Services
Acquisition in 2023
Heritage Environmental Services is a privately held environmental services firm based in Indianapolis, Indiana, with over 45 years of experience in the industry. The company specializes in providing a range of environmental management and consultancy services. Its offerings include waste treatment, landfill disposal, logistics, laboratory testing, industrial maintenance, and regulatory training. Heritage is committed to assisting clients in navigating environmental challenges while ensuring compliance with regulations and promoting sustainable practices.
Nouscom
Series C in 2023
Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates modified viral vector vaccines for cancer treatment. The company utilizes a range of engineered viral vectors optimized for the effective expression of long strings of tumor neoantigens. Additionally, its platform includes tools designed to induce broad and potent antitumor T-cell responses, which aim to enhance cancer-specific cellular immunity in patients.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.
MinervaX
Venture Round in 2023
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
VetPartners
Acquisition in 2023
VetPartners empowers their people to perform through education, guidance, support, simple processes and respectful relationships. They foster and create connection across their own network and the wider industry they work in. They are committed to doing what is right, being empathetic and supportive.
Wellhub
Series F in 2023
Wellhub is a corporate wellness platform designed to enhance employee engagement through improved physical activity. The company connects organizations with a diverse network of partners focused on fitness, emotional well-being, nutrition, and mindfulness. By offering a comprehensive subscription service, Wellhub enables employees to access various wellness options that promote lasting behavioral change and foster a healthier work environment. With over 2,000 clients, Wellhub is recognized for its ability to drive individual performance and overall business success by revolutionizing how employees engage in physical activity.
Xeltis
Series D in 2023
Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.
Dechra Pharmaceuticals
Acquisition in 2023
To continue to develop our position as an international, high margin, cash generative, specialist Veterinary Pharmaceuticals and related products business with clear focus on key therapeutic areas.
VarmX
Series B in 2023
VarmX is a pharmaceutical spin-off from the Leiden University Medical Center focused on developing and manufacturing therapeutic proteins aimed at restoring blood clotting in patients experiencing severe bleeding. The company's lead product, PseudoXa, is a modified recombinant human coagulation factor X designed to work effectively in the presence of direct factor Xa anticoagulants like rivaroxaban, apixaban, and edoxaban. These anticoagulants are widely used for preventing and treating thrombosis and stroke but can lead to dangerous bleeding as a side effect. PseudoXa addresses this critical issue by providing a means to stop and prevent bleeding, thereby enhancing the safety of anticoagulant therapies for millions of patients worldwide.
Evommune
Series B in 2023
Evommune, Inc. is a biotechnology company based in Los Altos, California, that focuses on developing and manufacturing tissue-based medicines aimed at treating inflammatory diseases. Founded in 2020, the company employs a proprietary tissue-based platform to accelerate the discovery of novel therapies, with a particular emphasis on immunology and dermatology. Evommune's approach seeks not only to alleviate the symptoms of inflammatory disorders but also to halt disease progression, thereby improving the quality of life for patients. Its pipeline includes initiatives targeting prevalent inflammatory conditions, with a commitment to advancing patient care by creating best-in-class treatment options. Through innovative strategies, Evommune aims to drive meaningful advancements in the field of inflammatory disease management.
Noya
Series A in 2023
Noya is focused on addressing climate change by retrofitting existing industrial equipment to capture carbon dioxide from the atmosphere. The company's innovative technology utilizes a non-toxic chemical blend that is added to the cooling towers of various industries without requiring any structural modifications. This approach allows for effective CO2 capture while enabling businesses to contribute to environmental sustainability. By selling the captured carbon dioxide to companies that utilize it as a raw material, Noya facilitates a practical and scalable solution for reducing carbon emissions and promoting a transition towards a carbon-negative future.
Lazer Logistics
Acquisition in 2023
Lazer Logistics specializes in providing outsourced yard management services to a diverse range of industries, including food and beverage, consumer packaged goods, e-commerce retail, and pulp and paper. The company offers comprehensive solutions that include yard spotting, trailer shuttling, rental services, and staffing for gate personnel. By managing the movement of loaded and empty trailers within customer yards and offsite locations, Lazer Logistics ensures efficient operations at production and distribution sites. Additionally, they implement computerized yard management systems and provide training to enhance safety and streamline processes for their clients.
GotPhoto
Acquisition in 2023
GotPhoto offers a software-as-a-service platform designed for photographers specializing in school and volume photography. The company provides a comprehensive system that streamlines the online sales process for photographers, enabling them to efficiently manage their workflow and e-commerce needs. By simplifying the process of selling photos, GotPhoto positions itself as a key resource for photographers looking to enhance their business operations and increase revenue.
Tion Renewables
Acquisition in 2023
Tion Renewables operates a European portfolio of wind and solar farms with an installed capacity.
IntegrityNext
Venture Round in 2023
IntegrityNext is a company based in Munich, Bayern, focused on providing a cloud-based platform for monitoring supplier sustainability and compliance. Established in April 2016 by Martin Berr-Sorokin, the platform allows businesses to automatically gather necessary supplier self-assessments and certifications while also monitoring social media for potential malpractice and reputational risks. Through its features, which include automated self-assessments, risk alerts, and a pre-built supplier questionnaire, IntegrityNext helps small and medium-sized enterprises navigate compliance data requirements set by international regulators. The platform's real-time dashboard and assessment framework enable companies to effectively manage compliance risks and streamline their processes.
SK Shielders
Acquisition in 2023
SK Shielders provides cyber security, physical security, convergence security, and safety care services. They also offer caps home door guard, caps home inner guard, caps unmanned guard, mobile guard, infosec cloud guard, caps cyber guard, caps smart walk-in, caps smart check, caps view guard AI, and caps mobile access card.
Xeltis
Series D in 2023
Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.
va-Q-tec
Acquisition in 2023
va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.
Cardiac Dimensions
Series D in 2023
Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.
EQT
Acquisition in 2023
EQT Partners AB is a private equity and venture capital firm based in Stockholm, Sweden, with a global presence through additional offices in major cities across Europe, Asia, and North America. Founded in 1994, EQT specializes in a wide array of investment strategies, including expansion capital, buyouts, and growth equity, focusing on medium to large-sized companies with consistent cash flows or significant intrinsic value. The firm targets various sectors, such as healthcare, technology, energy, and infrastructure, and emphasizes investments in mid-market situations, over-leveraged companies, and distressed assets. EQT's investment approach is characterized by taking controlling or co-controlling equity stakes in its portfolio companies and actively participating in their management, often securing board seats. The firm typically holds investments for four to eight years, aiming to enhance growth and create long-term value for stakeholders.
Madison Energy Infrastructure
Acquisition in 2022
Madison Energy Infrastructure is a platform that creates, owns, and manages renewable energy projects.
Cirba Solutions
Private Equity Round in 2022
Cirba Solutions is a circular supply chain for battery materials is created using a circular economy model, which recycles old resources and reintroduces them into the value chain for reuse with low waste. Cirba Solutions collects end-of-life batteries, processes them to extract critical materials, and reintroduces these materials into the supply chain. Cirba Solutions' battery recycling management platform provides battery-centric logistics, collection program solutions, second-life applications, and validate cathode production, all while emphasizing environmental compliance through technological processes.
SHL Medical
Secondary Market in 2022
SHL Medical AG is a Swiss company based in Zug that specializes in designing, developing, and manufacturing advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989, the company serves pharmaceutical and biotechnology companies worldwide by providing comprehensive services that include final assembly, labeling, and packaging. In addition to its core focus on drug delivery systems, SHL Medical also offers contract manufacturing services and produces various medical products such as pressure mattress systems and patient lifting slings. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring it delivers innovative solutions tailored to the needs of its clients.
Trescal
Acquisition in 2022
Trescal is a unique player in calibration services, independent from OEMs with expertise in all metrological domains. Every site is wholly dedicated to provide calibration solutions to enhance your industrial performance.
Storytel
Post in 2022
Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.
Vara
Series A in 2022
Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.
Billtrust
Acquisition in 2022
Billtrust is a provider of cloud-based software and integrated payment processing solutions designed to enhance B2B commerce by automating accounts receivable (AR) processes. Recognizing the inefficiencies of traditional, paper-based methods, Billtrust aims to digitally transform AR through a comprehensive platform that covers the entire order-to-cash cycle. This includes key functions such as credit decisioning, online ordering, invoicing, cash application, and collections. By integrating with various ecosystem participants, including financial institutions and enterprise resource planning systems, Billtrust enables businesses to transition from costly paper invoicing to efficient electronic billing and payments. This transformation accelerates revenue capture, improves cash flow, and enhances the overall user experience for clients.
etherna immunotherapies
Series B in 2022
eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.
FundamentalVR
Series B in 2022
FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.
United Talent Agency
Secondary Market in 2022
United Talent Agency (UTA) where they represent actors, writers, directors, recording artists, emerging technology companies, and corporate brands in a variety of industries, including film, television, music, digital media, intellectual property, computer and video games, commercials, voiceovers, endorsements, and entertainment marketing. Some of their clients are Johnny Depp, Harrison Ford, Owen Wilson, Gwyneth Paltrow, Jennifer Lopez, Paul Giamatti, Anthony Hopkins, Tim Robbins, Seth Rogen, James McAvoy, Ewan McGregor, Rachel McAdams, Paul Rudd, Don Cheadle, and Elizabeth Banks.
Xilis
Series A in 2022
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.
SPT Labtech
Acquisition in 2022
SPT Labtech specializes in designing and manufacturing automated instrumentation and consumables for life science research. Their product portfolio focuses on sample management, liquid handling, and multiplexed detection, which help to minimize assay volumes, enhance workflows, and reduce costs in fields such as drug discovery, structural biology, molecular biology, and genomics. By addressing existing customer challenges, SPT Labtech fosters innovation through its research and development efforts. The company prides itself on its deep application knowledge and engineering expertise, which allows it to support customers throughout the entire product lifecycle, from initial design to final manufacturing and sale. This comprehensive approach not only enhances productivity for life scientists but also strengthens client relationships through reliable technical and mechanical support.
ImCheck Therapeutics
Series C in 2022
ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
Ariceum Therapeutics
Series A in 2022
Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers. 177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, is an antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.
Envirotainer
Acquisition in 2022
Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company operates internationally with facilities in major locations such as Singapore, Dallas, Frankfurt, and Toronto, along with a network station in Hyderabad. Envirotainer serves a diverse clientele, including pharmaceutical and biotech companies, by offering a comprehensive suite of services that encompasses laboratory testing, qualification, validation support, and training through the Qualified Envirotainer Program. With over 30 years of experience, Envirotainer has established itself as a leader in secure cold chain solutions, ensuring that pharmaceutical products are transported in a controlled environment to meet the demands of the global market.
Redwood Capital Group
Acquisition in 2022
Redwood Capital Group, LLC leverages over 75 years of combined experience in the commercial real estate industry, targeting the acquisition and management of multi-family real estate. Its management team has handled in excess of eight billion dollars of commercial real estate investment, the lion’s share of which has been in multi-family assets. Our mission is to be the foremost choice for institutional and private equity in pursuit of strategic, multi-family investment. We deliver exceptional results to our investors and are uncompromising in our execution of strategy.
Guardian
Acquisition in 2022
Guardian is the local Chinese pest control operator, with a strong presence in Eastern and Southern China.
BPEA EQT
Acquisition in 2022
BPEA EQT is a prominent private alternative investment firm headquartered in Hong Kong, with a substantial commitment of over USD 20 billion in capital. Established in 1997, the firm specializes in private equity investments, focusing on buyouts and providing growth capital to companies, particularly within the Asia Pacific region, while also seeking global opportunities that can leverage expansion into this market. BPEA EQT manages dedicated funds in private real estate and private credit, reflecting its diverse investment strategy. With a workforce of over 180 employees across offices in key countries including China, India, Japan, Australia, and Singapore, the firm oversees approximately 43 active portfolio companies in Asia, collectively employing over 224,000 individuals and generating sales of around USD 39 billion.
Ardoq
Series D in 2022
Ardoq AS is a software company based in Oslo, Norway, with additional offices in New York, London, and Copenhagen. Established in 2013, Ardoq specializes in enterprise architecture solutions that facilitate the documentation and management of complex computer systems. Its platform combines textual documentation with interactive visualizations, allowing users to generate diagrams and insights in real-time. Ardoq's features include business capability mapping, risk and security architecture, and data flow integration, all designed to support organizations in their digital transformation efforts. The software enhances collaboration among developers, project managers, architects, and stakeholders by providing dynamic overviews and dashboards that highlight the interdependencies between technology and organizational processes.
LSP
Acquisition in 2022
LSP is a defense & space company that offers strategy consulting services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.